Compare · head to head
Innovent Biologics vs Persol Holdings
Persol Holdings ranks higher overall — 360 rank 98 vs 68.
Persol Holdings leads on Value (80 vs 40) and Growth (65 vs 49). Innovent Biologics leads on Quality (67 vs 58) and Sentiment (51 vs 46). The two are close on Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | China | Japan |
| Sector | Health Care | Business Services |
| Industry | Biotechnology | Professional Services |
| Size | Large | X-Large |
| ISIN | KYG4818G1010 | JP3547670004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 68 | 98 |
| Value | 40 | 80 |
| Quality | 67 | 58 |
| Growth | 49 | 65 |
| Safety | 62 | 65 |
| Sentiment | 51 | 46 |
| Quality details | ||
| Profitability | 60 | 69 |
| Cash Truth | 74 | 46 |
Innovent Biologics vs Samsung EpisInnovent Biologics vs CelltrionInnovent Biologics vs MesoblastInnovent Biologics vs GC BiopharmaAdd a third stock →
Full analyses: Innovent Biologics · Persol Holdings
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100